Authors


Uma Menon, MD, MBA

Latest:

Unusual New Onset Seizures in a Healthy, Young Adult Male

A 23-year-old male college student presents with first generalized tonic-clonic seizure followed by episodes of violent psychosis.


Matt Hoffman

Latest:

NeurologyLive® Brain Games: January 21, 2024

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is headache and migraine.


Lauryn Currens, MD

Latest:

Using the Ketogenic Diet to Treat Intractable Epilepsy in Case of Glycine Encephalopathy

A boy diagnosed with glycine encephalopathy in the newborn period was initiated on the ketogenic diet at 11 years-old for the treatment of medication refractory epilepsy.


Mayte Sánchez van Kammen, MD

Latest:

Understanding Cerebral Venous Thrombosis: Rare But Sometimes Fatal

The prognosis of cerebral venous thrombosis (CVT) is favorable compared with other types of stroke: almost 80% of patients with CVT recover without functional disability. Nevertheless, 5% to 10% of patients die in the acute phase.


Susanna M. Zuurbier, MD, PhD

Latest:

Understanding Cerebral Venous Thrombosis: Rare But Sometimes Fatal

The prognosis of cerebral venous thrombosis (CVT) is favorable compared with other types of stroke: almost 80% of patients with CVT recover without functional disability. Nevertheless, 5% to 10% of patients die in the acute phase.


Jonathan M. Coutinho, MD, PhD

Latest:

Understanding Cerebral Venous Thrombosis: Rare But Sometimes Fatal

The prognosis of cerebral venous thrombosis (CVT) is favorable compared with other types of stroke: almost 80% of patients with CVT recover without functional disability. Nevertheless, 5% to 10% of patients die in the acute phase.


Laura C. Spetlz, MD

Latest:

Case Report: New Onset Paroxysmal Episodes in an Infant

A newborn presents with new onset episodes of lateral gaze deviation with extremity stiffening.


Tori Rodriguez, MA

Latest:

Closing the Treatment Gap in Progressive MS

New biomarkers of disease activity may help better vet investigational therapies aimed at slowing the insidious neurodegeneration seen in primary progressive multiple sclerosis.


Marco Meglio

Latest:

Addressing Potential Causes of Burnout Through Productive Solutions: Neil Busis, MD

The associate chair for technology and innovation at the NYU Grossman School of Medicine provided commentary on a study from AAN 2024 that examined the driving factors behind burnout in neurology departments. [WATCH TIME: 4 minutes]


Lauren Speltz, MD

Latest:

Cyclic Vomiting, Incontinence in a Young Boy

An 8 year old boy with genetically confirmed neurofibromatosis type 1 presents with first generalized seizure.

© 2024 MJH Life Sciences

All rights reserved.